Serina Therapeutics SER
NYSE SER
$1.78 +0.01 (+0.56%)
As of: Oct 22, 2026 · 2:35 PM EDT

Serina Therapeutics (SER) Receivables - Other (2018 - 2024)

Updated

Serina Therapeutics (SER) posted Receivables - Other of $14,000 for Q3 2024, down 72.5% from the prior quarter.

Analysis

Serina Therapeutics (SER) Receivables - Other (2018 - 2024) Analysis & Trends

At the end of FY2018, Serina Therapeutics' Receivables - Other came in at $78,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Serina Therapeutics 29.17 Mn -11.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 14,000.00
Jun 30, 2024 51,000.00
Jun 30, 2019 78,000.00
Mar 31, 2019 16,000.00
Dec 31, 2018 78,000.00
API Access

Serina Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SER&period=max&api_key=YOUR_API_KEY